VHLH抗原,脑视网膜血管瘤G7蛋白抗原(逢希伯-林道氏病)
时间:2024-11-20 阅读:16
-
提供商
上海允麦生物科技有限公司 -
资料大小
32282 -
资料图片
-
下载次数
0次 -
资料类型
jpg -
浏览次数
16次
时间:2024-11-20 阅读:16
提供商
上海允麦生物科技有限公司资料大小
32282资料图片
下载次数
0次资料类型
jpg浏览次数
16次Recombinant human VHLH
pVHL; pVHL; G7 protein; Elongin binding protein; HRCA 1; HRCA1; Protein G7; pVHL; RCA 1; RCA1; VHL 1; VHL; VHL_HUMAN; VHL1; VHLH; Von Hippel Lindau disease tumor suppressor; von Hippel Lindau syndrome; von Hippel Lindau tumor suppressor; Von Hippel-Lindau disease tumor suppressor.
浓度:1mg/ ml
来源:Recombinant Human
纯度:≥95% SDS-PAGE
表达系统:Escherichia coli
标签:His tag
蛋白长度:Full length protein
内毒素水平:<1.000 Eu/µg
纯化方法:HPLC
应用:SDS-PAGE,Western blot,ELISA
Biological activity,immunology research
保存:-20℃
保质期:1年
Involved in the ubiquitination and subsequent proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Seems to act as target recruitment subunit in the E3 ubiquitin ligase complex and recruits hydroxylated hypoxia-inducible factor (HIF) under normoxic conditions. Involved in transcriptional repression through interaction with HIF1A, HIF1AN and histone deacetylases.
产品名称:Rabbit Anti-VHLH antibody
Rabbit Anti-VHLH
别名:pVHL; pVHL; G7 protein; Elongin binding protein; HRCA 1; HRCA1; Protein G7; pVHL; RCA 1; RCA1; VHL 1; VHL; VHL_HUMAN; VHL1; VHLH; Von Hippel Lindau disease tumor suppressor; von Hippel Lindau syndrome; von Hippel Lindau tumor suppressor; Von Hippel-Lindau disease tumor suppressor.
来源:Rabbit
克隆类型:Polyclonal
浓度:1mg/ml
亚型:IgG
应用: WB=1:1000-1:2000,Elisa=1:1000-1:2000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100-500,IF=1:100-500
反应:Human
免疫原:KLH conjugated synthetic peptide derived from human VHLH
保存:-20℃
保质期:1年
单克隆抗体
产品名称:Anti-VHLH antibody
Mouse Anti-VHLH
别名:pVHL; pVHL; G7 protein; Elongin binding protein; HRCA 1; HRCA1; Protein G7; pVHL; RCA 1; RCA1; VHL 1; VHL; VHL_HUMAN; VHL1; VHLH; Von Hippel Lindau disease tumor suppressor; von Hippel Lindau syndrome; von Hippel Lindau tumor suppressor; Von Hippel-Lindau disease tumor suppressor.
来源:Mouse
克隆类型:Monoclonal
浓度:1mg/ml
亚型:IgG
应用: WB=1:1000-1:2000,Elisa=1:1000-1:2000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100-500,IF=1:100-500
反应: Human
免疫原:KLH conjugated synthetic peptide derived from human VHLH
保存:-20℃
保质期:1年
Involved in the ubiquitination and subsequent proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Seems to act as target recruitment subunit in the E3 ubiquitin ligase complex and recruits hydroxylated hypoxia-inducible factor (HIF) under normoxic conditions. Involved in transcriptional repression through interaction with HIF1A, HIF1AN and histone deacetylases.